Use of sIFNAR2 in the treatment of SARS-CoV-2 infection (Machine-translation by Google Translate, not legally binding)

Use of sIFNAR2 in the treatment of SARS-CoV-2 infection (Machine-translation by Google Translate, not legally binding)

Use of the soluble receptor sIFNAR2 in the treatment of SARS-CoV-2 coronavirus infection and compositions comprising said protein. (Machine-translation by Google Translate, not legally binding) Uso del receptor soluble sIFNAR2 en el tratamiento de la infección por el coronavirus SARS-CoV-2 y composi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pavía Molina, José, Oliver Martos, Begoña, Alcamí Pertejo, Antonio, Sola Gurpegui, María Isabel, Hurtado Tamayo, Jesús, Enjuanes Sánchez, Luis, Fernández Fernández, Oscar, Hurtado Guerrero, Isaac
Format: Patent
Sprache:eng ; spa
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Use of the soluble receptor sIFNAR2 in the treatment of SARS-CoV-2 coronavirus infection and compositions comprising said protein. (Machine-translation by Google Translate, not legally binding) Uso del receptor soluble sIFNAR2 en el tratamiento de la infección por el coronavirus SARS-CoV-2 y composiciones que comprenden dicha proteína.